UroGen Pharma Ltd.

URGN Stock Healthcare Biotechnology
$34.56
-2.05 (-5.60%)
Price as of Oct 16, 2026 market close

Performance

1 Month
-21.4%

Price return, based on split- and dividend-adjusted closing prices.

Risk

Largest decline max drawdown, since Aug 2026
-31.3%

Own URGN?

See how URGN contributes to your portfolio's return, allocation, and risk.

7-day free trial, then $9/month.